MORGAN WYRICK: Open Payments
NPI 1134845746 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 29 payments from 12 companies in 2025. Trend: 2023 $213 · 2024 $199 · 2025 $487
Food & beverage: $455Education: $32
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $141 |
| Alnylam Pharmaceuticals Inc. | 5 | $79 |
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
| Boston Scientific Corporation | 1 | $33 |
| Novo Nordisk Inc | 1 | $32 |
| HEARTFLOW, INC. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| CVRx, Inc. | 1 | $21 |
| AtriCure, Inc. | 1 | $18 |
| BridgeBio Pharma, Inc. | 1 | $17 |
Products named: LEQVIO, AMVUTTRA, CAMZYOS, BodyGuardian, Ozempic, FFRct, COBENFY, EVKEEZA.
Industry payments across AR — which companies pay providers there.
